Abbott Laboratories (ABT)
Medical - Devices · Healthcare · $154.5B
Intrinsic Value (Consensus)
$50.05
Current Price
$88.43
Margin of Safety
-43.4%
43.4% Above Intrinsic Value
Value: $50
Price: $88
Valuation Model Estimates
Current Price: $88.43
DCF (Discounted Cash Flow)
$64.55
Graham Number
$49.08
Earnings Power Value
$45.59
Relative Value (P/E)
$71.81
Dividend Discount Model
$19.21
Consensus Value
$50.05
Model Assumptions
Discount Rate
10.3%
Growth Rate
4.6%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
C
60
Profitability
18/25
Strength
25/25
Valuation
7/25
Growth
10/25
Financial Health Signals
Low debt — conservative balance sheet
Key Financials
- EPS (TTM)
- $3.59
- EPS (Forward)
- $3.76
- Book Value
- $29.82
- P/E Ratio
- 23.7
- Forward P/E
- 23.2
- PEG Ratio
- —
- ROE
- 12.5%
- Debt/Equity
- 25%
- Revenue Growth
- 5.7%
- Earnings Growth
- 4.6%
- Dividend Yield
- 0.7%
- Beta
- 0.60
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-21
Source: Yahoo Finance